EWM
SRRA

Elmwood Wealth Management’s Sierra Oncology, Inc. Common Stock SRRA Stock Holding History

Elmwood Wealth Management’s Portfolio SRRA Stock Details SRRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-1,140
Closed -$25K – 353
2021
Q4 		$25K Buy
+1,140
New +$25.1K 0.01% 236
2021
Q2 		$20K Hold
1,040
– – 0.01% 222
2021
Q1 		$18K Buy
+1,040
New +$16.5K 0.01% 223

Other funds holding SRRA

VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
A
Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Elmwood Wealth Management's SRRA Position: Q1 2022 in Review

Elmwood Wealth Management sold out of Sierra Oncology, Inc. Common Stock (SRRA) in Q1 2022, closing a stake of 1,140 shares — an estimated $25K sold.

Elmwood Wealth Management first reported a position in SRRA in Q1 2021 and held it in 3 quarters. The position peaked at $25K in Q4 2021. 75 funds tracked by Wall St. Rank hold SRRA as of Q1 2022.

  • Elmwood Wealth Management reported no remaining Sierra Oncology, Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
  • Elmwood Wealth Management sold 1,140 Sierra Oncology, Inc. Common Stock shares in Q1 2022, an estimated $25K.
  • Elmwood Wealth Management first reported a position in Sierra Oncology, Inc. Common Stock in Q1 2021 and held it in 3 quarters.
  • Elmwood Wealth Management's Sierra Oncology, Inc. Common Stock position peaked at $25K in Q4 2021.
  • 75 funds tracked by Wall St. Rank held Sierra Oncology, Inc. Common Stock as of Q1 2022.

Based on Elmwood Wealth Management's 13F filing for Q1 2022, filed 16 May 2022.